Lee's Pharmaceutical Holdings Ltd (SEHK:950)

APAC company
add to virtual portfolio
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - 950

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - 950

  • Market CapHKD0.000m
  • SymbolSEHK:950
  • IndustryHealthcare
  • SectorDrug Manufacturers - Specialty & Generic
  • Currency
  • ISINKYG5438W1116

Company Profile

Lee's Pharmaceutical Holdings Ltd is a Cayman Island-based research-driven and market-oriented biopharmaceutical company. It is integrated with solid infrastructures in drug development, clinical development, regulatory, manufacturing, sales, and marketing in China with global perspectives. It focuses on cardiovascular and infectious diseases, dermatology, oncology, gynecology, ophthalmology, and others. Its portfolio has two categories of Proprietary products and Licensed-in products. Its maximum revenue is generated from China. The Proprietary Products portfolio includes Livaracine, Yallaferon, Eyprotor. And its License-in Products include Carnitene, Ferplex, ALOXI, Zanidip, Dafnegin, Veloderm, Levocarnitine Oral Solution, Remodulin.Lee's Pharmaceutical Holdings Ltd through its subsidiaries, develops, manufactures and markets pharmaceutical products. It is engaged in areas such as cardiovascular, dermatology, oncology, gynecology and ophthalmology.

Latest 950 news

Currently there for this company. Visit our news hub for other news .